Search
Technetium Tc-99m sestamibi
go.drugbank.com/drugs/DB09161ApprovedInvestigationalThe mechanism by which sestamibi localizes to these tissues has not been established.
KD7040
go.drugbank.com/drugs/DB05214InvestigationalThe KD7040 IND was filed in 4Q06, and a Phase Ib clinical trial began 2Q07. It is being developed by Kalypsys.
D-JNKI-1
go.drugbank.com/drugs/DB05660InvestigationalA synthetic, cell permeable peptide that blocks the MAPK-JNK signal pathway; has potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the
Deferitazole
go.drugbank.com/drugs/DB13120InvestigationalIt has been used in trials studying the treatment and basic science of Beta-thalassemia, Hepatic Impairment, Impaired Renal Function, Transfusional Iron Overload, and Iron Overload Due to Repeated Red
Azintuxizumab vedotin
go.drugbank.com/drugs/DB14847InvestigationalAzintuxizumab vedotin is under investigation in clinical trial NCT02951117 (A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has
Ancriviroc
go.drugbank.com/drugs/DB19773ExperimentalAncriviroc has a monoisotopic molecular weight of 556.2 Da.
Diclofenac etalhyaluronate
go.drugbank.com/drugs/DB20937ExperimentalDiclofenac etalhyaluronate has a monoisotopic molecular weight of 1475.39 Da.
Firuglipel
go.drugbank.com/drugs/DB19506InvestigationalFiruglipel has a monoisotopic molecular weight of 467.19 Da.
Xemilofiban
go.drugbank.com/drugs/DB21058ExperimentalXemilofiban has a monoisotopic molecular weight of 358.16 Da.